Related Experiment Video
Updated: Nov 7, 2025

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
Glycosylation of Therapeutic Proteins: A Critical Quality Attribute
1Quality Assistance sa, Technoparc de Thudinie 2, Donstiennes, Belgium. arnaud.delobel@quality-assistance.be.
Abstract:
Glycosylation is a common posttranslational modification of therapeutic proteins. The glycosylation pattern is dependent on many parameters such as the host cell line or the culture conditions. N- and O-linked glycans usually play a great role on the stability, safety, and efficacy of the drug. For this reason, glycosylation is considered as a critical quality attribute of therapeutic glycoproteins, and a thorough characterization should be performed, as well as a systematic control for each batch produced. This chapter gives a short presentation of the structure of glycans commonly found on recombinant therapeutic proteins, and their role on the properties of the drug, in terms of stability, pharmacokinetics, safety, and efficacy. Lastly, the use of mass spectrometry for the analysis of glycoproteins is briefly described.
Related Concept Videos
Protein Glycosylation
Glycosylation occurs in...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Proteoglycans
Protein Folding Quality Check in the RER
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Matrix Proteoglycans and Glycoproteins

